Action is seen on the shares of the stock companies of the listed companies of the stock market or the decisions taken by the government. Some companies announce their decisions after market close and some companies make their decisions public during market hours. Sometimes such information about companies is also filtered from other sources, which has a favorable or unfavorable effect on their stocks. Keeping this in mind, we provide daily information about such stocks or companies in the form of Buzzing Stocks for the investors, which will be in the headlines or focus during the market today due to some reason.
CIPLA in focus
The promoters of pharmaceutical company Cipla will sell about 2.5 per cent stake on Tuesday, February 15, for Rs 1,844 crore. This information has been revealed by quoting the termsheet issued by Kotak Securities. Cipla Chairman Yusuf Hameed and Non-Executive Vice Chairman Mustafa Hameed will sell their stake in Cipla through a block deal for which the floor price has been fixed at Rs 904.8-916.7 per share. It is at a discount of up to 5.25 per cent from Monday’s closing price of Rs 955 on NSE.
Focus on Vedanta
Has tied up with Foxconn for the manufacturing of semiconductors. The company will have a majority stake in Vedanta-Foxconn’s JV. Anil Agarwal will be the chairman of the new JV.
RELIANCE IND IN FOCUS
JIO PLATFORMS has announced an investment of 20 crore DOLLAR i.e. about 1500 crore rupees in TECH START UP GLANCE. GLANCE PROVIDES PERSONALIZED CONTENT ON LOCK MOBILE SCREEN. Akash Ambani, director of JIO PLATFORMS, said that the global launch of GLANCE will help.
EQUITAS SFB IN FOCUS
There is a preparation to raise Rs 550 crore through QIP. The issue price of the QIP has been fixed at `53.59/share with a discount of 0.94%.
The market may fall further, Nifty may touch the previous swing of 16,410: Vinay Rajani
FOCUS ON GODREJ CONSUMER
Sold MamaEarth to hair color brand BBlunt for 84.5 Cr.
Order has been received from HAL for 83 Tejas MK1A aircraft. Order has been placed for Compact Heat Exchanger Supply. Working with DRDO for Air Cycle Machine.
Focus on Cadilla Health
Zydus’s Roflumilast tablet gets shared exclusive rights. Shared exclusive rights are available in the US for 180 days. Medicine is used in the treatment of Lungs.
,